Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-09-11 | Amended | $1,699,986 | $1,549,991 | Equity Only | 06b | SEC link |
| 2023-09-22 | New | $149,995 | $149,995 | Equity Only | 06b | SEC link |
| 2019-09-23 | New | $1,374,981 | $1,374,981 | Equity Only | 06b | SEC link |
| 2018-12-27 | New | $19,325,000 | $19,325,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Allan Clarke | Director, Executive |
| Charlene Messinger | Executive |
| Kevin J. O'neill | Director, Executive |
| Hitha Palepu | Director, Executive |
| Nagesh Palepu | Director |